Author(s)

J. Biederer, S. Mirsadraee, M. Beer, F. Molinari, C. Hintze, G. Bauman, M. Both, E. J. Van Beek, J. Wild, M. Puderbach

ISBN

1869-4101 (Electronic) 1869-4101 (Linking)

Publication year

2012

Periodical

Insights Imaging

Periodical Number

4

Volume

3

Pages

373-86

Author Address

Department of Diagnostic Radiology, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Strasse. 3, Haus 23, 24105, Kiel, Germany, juergen.biederer@rad.uni-kiel.de.

Full version

BACKGROUND: MRI of the lung is recommended in a number of clinical indications. Having a non-radiation alternative is particularly attractive in children and young subjects, or pregnant women. METHODS: Provided there is sufficient expertise, magnetic resonance imaging (MRI) may be considered as the preferential modality in specific clinical conditions such as cystic fibrosis and acute pulmonary embolism, since additional functional information on respiratory mechanics and regional lung perfusion is provided. In other cases, such as tumours and pneumonia in children, lung MRI may be considered an alternative or adjunct to other modalities with at least similar diagnostic value. RESULTS: In interstitial lung disease, the clinical utility of MRI remains to be proven, but it could provide additional information that will be beneficial in research, or at some stage in clinical practice. Customised protocols for chest imaging combine fast breath-hold acquisitions from a “buffet” of sequences. Having introduced details of imaging protocols in previous articles, the aim of this manuscript is to discuss the advantages and limitations of lung MRI in current clinical practice. CONCLUSION: New developments and future perspectives such as motion-compensated imaging with self-navigated sequences or fast Fourier decomposition MRI for non-contrast enhanced ventilation- and perfusion-weighted imaging of the lung are discussed. Main Messages * MRI evolves as a third lung imaging modality, combining morphological and functional information. * It may be considered first choice in cystic fibrosis and pulmonary embolism of young and pregnant patients. * In other cases (tumours, pneumonia in children), it is an alternative or adjunct to X-ray and CT. * In interstitial lung disease, it serves for research, but the clinical value remains to be proven. * New users are advised to make themselves familiar with the particular advantages and limitations.